Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sequoia Capital China Raising $2.2 Billion in RMB for China Fund

publication date: Sep 23, 2020

Sequoia Capital China is raising $2.2 billion for a new yuan-denominated fund, the company's sixth fund. The company has invested in about 600 China companies in sectors that include TMT, healthcare, consumer/service, and industrial technology over the past 15 years. Sequoia China's website lists 40 healthcare members of its portfolio, including Innovent, CStone, Zai Lab and Venus MedTech. The new fundraising is significant because it shows Sequoia, a US company, is committed to building its China business, despite rising diplomatic tensions between the two countries. More details...

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital